MF

20 drugs in development·14 companies·2 clinical trials

Drug Pipeline by Phase

Approved(11)

Drug	Company
bromfenac	Amneal Pharmaceuticals, Inc. (AMRX)
bromfenac	Aptinyx Inc. (APTX)
colchicine	Mylan II B.V. (MYL)
deflazacort	Amneal Pharmaceuticals, Inc. (AMRX)
lisdexamfetamine di	Mylan II B.V. (MYL)
lisdexamfetamine di	Amneal Pharmaceuticals, Inc. (AMRX)
lisdexamfetamine di	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
mycophenolate mofetil	Amneal Pharmaceuticals, Inc. (AMRX)
nexobrid	MediWound Ltd. (MDWD)
pemfexy	EAGLE PHARMACEUTICALS, INC. (EGRX)
VELDONA Pet supplement	Ainos Inc. (AIMD)

Phase 3(2)

Drug	Company
navitoclax	AbbVie Inc. (ABBV)
pelabresib	Novartis AG (NVS)

Phase 2(2)

Drug	Company
cpi-0610	CONSTELLATION PHARMACEUTICALS INC (CNST)
envafolimab	Tracon Pharmaceuticals, Inc. (TCON)

Phase 1(1)

Drug	Company
pelabresib	Novartis AG (NVS)

Preclinical(3)

Drug	Company
dmr-001	Damora Therapeutics, Inc. (DMRA)
uroshield	ENvue Medical Inc. (FEED)
uroshield ultra	ENvue Medical Inc. (FEED)

Unknown(1)

Drug	Company
CellFX nsPFA 360° Cardiac Catheter	Pulse Biosciences Inc Common Stock (DE) (PLSE)

BioSniper tracks 20 drugs in development for MF across 14 companies.

There are 2 clinical trials targeting MF tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.